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Abstract
Background: Clinical signs and consequences of Cushing's syndrome are likely to
impact upon a dog's life. Quantification of this impact on a dog's health-related
quality-of-life (HRQoL) could contribute to optimized disease management.
Hypothesis/objectives: To develop a novel HRQoL tool to aid assessment of dogs
with Cushing's syndrome and to evaluate factors that impact upon dogs living with
this disease.
Animals: Two hundred and ten dogs with Cushing's syndrome and 617 dogs without
Cushing's syndrome.
Methods: Cross-sectional study design. Dog owners answered questions relating to
the HRQoL of their dogs which were refined to develop the final tool. The tool was
analyzed for reliability, validity, and interpretability, including Cronbach's alpha and
principal components analysis. Factors impacting upon the HRQoL of dogs with Cus-
hing's syndrome were assessed using appropriate nonparametric tests.
Results: The tool was refined from 32 questions to 19 and showed good internal
consistency (α = .83). Owners rated questions related to “owner impact” as more
important and those related to demeanor as less important. There was a positive cor-
relation between the tool score of dogs with Cushing's syndrome and owner's assess-
ment of their dog's quality-of-life (r = .41, P < .001). Dogs currently on treatment
with trilostane had a statistically better HRQoL (.33, interquartile range [IQR] .23–.44)
than those not receiving trilostane (.36, IQR .33–.54, P = .04).
Conclusions and Clinical Importance: The developed tool quantifies the HRQoL of
dogs with Cushing's syndrome and could assist clinicians in the clinical assessment of
dogs with Cushing's syndrome.
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IQR, interquartile range; KMO, Kaiser–Meyer–Olkin measure of sampling adequacy; PCA,
principal components analysis.
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1 | INTRODUCTION
Assessing the quality-of-life of animals is an integral role of a veteri-
narian and is required during decision-making on treatment and
euthanasia to optimize the health and welfare of animals under their
care.1 In the current study, health-related quality-of-life (HRQoL)
refers to the state of an individual animal's life as thought to be per-
ceived by them at a point in time by their owner. This includes the
physical, social, and environmental needs and impacts which are
reflected by the animal's health and behavior.2 A fundamental issue
currently is that assessment of welfare or quality-of-life is not stan-
dardized or validated. The assessment is nearly always subjectively
and compassionately inferred by veterinary professionals and animal
owners. Consequently, quantification is increasingly promoted to opti-
mize and standardize decision-making in this area.2-4 The British Vet-
erinary Association's Animal Welfare Strategy highlighted the use of
welfare assessments as 1 of their 6 priorities, which includes the use
of practice-based quality-of-life assessments.5 In human medicine,
formal HRQoL measures are commonly implemented in practice
to provide additional information about the dogs without solely
assessing laboratory results or clinical outcomes.6 It is accepted that
lack of assessment on a dog's HRQoL could result in inadequate relief
from suffering and suboptimal clinical decision-making4,7 with an
awareness that the severity of the clinical signs affecting an individual
might correlate poorly with results of routine blood tests.8 Practice-
based quality-of-life tools developed for veterinary medicine have
followed the methodology produced in human medicine to measure
HRQoL.2,9-14
Cushing's syndrome in dogs results from excessive circulating glu-
cocorticoids. The disease is clinically characterized variably by polyuria
and polydipsia, polyphagia, bilateral alopecia, muscle atrophy with
generalized weakness, hepatomegaly, systemic hypertension, and
lethargy.15,16 These clinical signs can all impact upon dogs' as well as
to their owner's lives. Currently no tool to quantify the impact or the
long-term residual effects of Cushing's syndrome on a dog's life has
been published. Therefore, such a tool is warranted to optimize dis-
ease management, taking the financial and emotional strain of Cus-
hing's syndrome to the owner into consideration in its design. Any
negative impact of disease and treatment on the owner could lead to
cessation of treatment or even euthanasia.
The aims of this study were to develop a novel HRQoL tool to aid
clinical assessment of dogs with Cushing's syndrome and to evaluate
factors that might impact upon the quality-of-life of dogs with this
disease. It was hypothesized that Cushing's syndrome cases not
receiving treatment would have a poorer HRQoL.
2 | METHODS
HRQoL tool development followed a standard psychometric process
of item identification, selection, and refinement.9,10,17,18 An item was
defined as any aspect of Cushing's syndrome and its management that
could potentially impact on a dog's HRQoL. Health-related quality-of-
life tools must be shown to be valid, reliable, and interpretable before
recommending their use in a clinical context.8,12,18 Ethical approval
was granted by the Royal Veterinary College Ethics and Welfare Com-
mittee (URN 2015 1373).
2.1 | CushQoL-pet development
2.1.1 | Item identification
Items potentially impacting the HRQoL of Cushing's syndrome in dogs
were identified through a variety of sources. A focus group discussion,
face-to-face interviews, and telephone interviews were conducted with
veterinarians (16 primary-care practitioners, 2 internal medicine special-
ists, and a dermatologist), 2 veterinary nurses and 13 owners of dogs
with Cushing's syndrome. A list of guiding, open-ended questions
regarding possible effects of this disease on HRQoL was applied, with
all the answers transcribed for qualitative interpretation. A broader
overview of potential items was identified from review of the relevant
literature, an interview with a human Cushing's syndrome patient and
2 developers of a human Cushing's syndrome HRQoL tool17 as well as
review of 20 randomly selected electronic health records from primary-
care caseloads of dogs with Cushing's syndrome.19
2.1.2 | Item selection
A questionnaire was designed to explore all identified items. A pilot of
the questionnaire was performed by owners of dogs both with and
without Cushing's syndrome, veterinarians, specialists in animal
behavior and welfare, and veterinary epidemiologists to identify
ambiguous, unnecessary, or missing questions that needed revision.
Questions were designed from the transcripts to reflect the phrases
and words used by owners and veterinarians.
The final amended questionnaire was uploaded to an online sur-
vey tool (SurveyMonkey, San Mateo, California). Owners of dogs,
both with and without Cushing's syndrome, were eligible to complete
the questionnaire. Responses were excluded if they were incomplete
or had been completed retrospectively by the owner regarding
deceased animals. The questionnaire was promoted via veterinary
practice client e-mails and practice posters, website links, and social
media posts. The Royal Veterinary College, Veterinary Information
Network, Dechra Veterinary Products Ltd, Vets4Pets, Independent
Vet Care, Dogs Trust, and the Dog Science Group all promoted the
questionnaire.
Owners were asked to describe the frequency of each specified
item impacting on their dog's life over the previous week. Responses
were assigned a score (all the time (3), often (2), occasionally (1), never
(0) for negatively phrased questions). The scores were reversed in
positively phrased questions.
2.1.3 | Item refinement
To develop the finalized “CushQoL-pet” tool, the questions included
were refined based on statistical analysis of the responses.
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1. Chi-squared analysis was performed on each item, comparing the
results from dogs with and without Cushing's syndrome. Items
with at least weak evidence of differences between the 2 groups
were retained as these were deemed specific to the impact of
Cushing's syndrome on HRQoL (P < .20).
2. Internal consistency of the questionnaire was measured by Cronbach's
alpha, using only the responses of owners of dogs with Cushing's syn-
drome. Internal consistency indicates the reliability of the questions to
measure the same latent concept.20 In the context of this study, the
latent concept was “HRQoL.” Cronbach's alpha was calculated using a
1-way repeated measure analysis of variance model, with HRQoL
question responses functioning as the repeated measure. Initially, cor-
relations were examined in an inter-item correlation matrix to assess
how much each individual question responses correlated with all
included questions. Low correlations (r < .30) were deemed poor and
those questions were removed if the overall Cronbach's alpha coeffi-
cient increased after removal. Correlations between pairs of questions
were examined to check whether they were deemed highly correlated
(r > .60), suggesting the same information is being captured twice
therefore falsely raising the internal consistency of the tool.21 The
question with the smallest effect on the Cronbach's alpha was
removed. An overall test Cronbach's alpha of α > .70 for the retained
questions was deemed an appropriate internal consistency.22
Internal validation using the dog's name, age, sex, and breed
prevented duplication of responses relating to a single dog. If dupli-
cates were found, the earliest response was used for analysis.
2.2 | Interpretation, validation, and reliability of
CushQoL-pet
After refinement of the tool, the finalized questions were utilized to
produce a combined score of HRQoL, rating between 0 and 1 (0 indi-
cating the best possible HRQoL and 1 indicating the worst possible).
The scoring was calculated as follows:
CushQoL−petScore =Σof the question scores=total maximum score
Questions were included in the questionnaire to assess the validity
of the tool. One question asked owners to describe their dog's current
quality-of-life on a 7 point scale (from “as good as it could be” to “as
poor as it could possibly be”), to assess construct validity. Correlations
were analyzed with Spearman's rank correlation. Wilcoxon rank-sum
and Kruskal-Wallis tests compared CushQoL-pet scores of dogs with
and without Cushing's syndrome. Dogs with and without Cushing's
syndrome were further categorized by (1) age group (<7, 7–11,
>11 years), and (2) health status (“healthy” and “not-healthy” group, if a
disease other than Cushing's syndrome was reported by the owner).
Principal components analysis (PCA) assessed the underlying
structure and identified subsets within the CushQoL-pet tool. The
principal components describing the largest amount of data variation
were retained for further interpretation. Retention was based on visu-
alization of the decreasing proportion of data variance described by
each principal component, using a scree-plot.21,23 For each retained
principal component, the HRQoL question loading scores were ana-
lyzed and interpreted to observe those with the greatest influence on
each principal component. Loadings closest to −1 or 1 for an item
indicate a strong influence on the component.21 A loading of ≥0.3 was
selected as an appropriate cutoff.10,24 The internal consistency of the
identified subsets was examined with Cronbach's alpha. The Kaiser–
Meyer–Olkin (KMO) measure of sampling adequacy was used post-
estimation to assess whether the patterns of correlation from the
PCA were relatively compact and therefore the results were reliable.25
KMO values >.50 indicate adequate sampling.
To assess the reliability of the tool, inter-rater measures of the
questionnaire were assessed on 13 dogs, with pairs of owners of the
same dog completing the questionnaire independently of each other.
Intra-rater reliability was carried out with 15 owners to examine the
stability of the responses from the same person carrying out the ques-
tionnaire at an interval of 2 weeks, with no changes to the management
of their dog's Cushing's syndrome. Paired scores were assessed with
the intraclass correlation coefficient (ICC), with results interpreted as
poor reliability (<.50), moderate (.50 to <.75), good (.75 to <.90), and
excellent (≥.90).26 Bland–Altman plots were analyzed to assess score
agreement between 2 owners and repeat response at a 2 week inter-
val.27,28 These scores helped inform the suitability of questions for
inclusion in the tool. Seventy-one owners of dogs with Cushing's syn-
drome repeated the CushQoL-pet at least 3 months after their first
response. These follow-up responses were used to assess the test-
retest reliability of the score. Owners answered additional questions
relating to changes in their dog's management and quality-of-life since
their previous response. Correlation between the differences in the
2 CushQoL-pet scores and the owner assessment of a change in
quality-of-life were assessed with Spearman's rank correlation.
2.3 | Evaluation of factors impacting the HRQoL of
dogs with Cushing's syndrome
The online questionnaire also asked owners to provide some addi-
tional information as well as the core questions. Owners assessed the
importance of each HRQoL question to themselves and their dog
(very important (4), important (3), moderately important (2), low
importance (1), not at all important (0)).10 Inter-rater and intra-rater
reliability assessments of owner reported importance were also car-
ried out as described above. Additional demographic information
relating to their dog included age, breed, sex, weight, insurance status,
and other health concerns. Specific questions about owners included
owner lifestyle, time spent with their dog, and whether they were the
primary care-giver. Owners of dogs with Cushing's syndrome were
asked disease-specific questions, including treatment currently
received, time since diagnosis and how their dog's quality-of-life had
changed since their diagnosis. Differences between dogs with and
without Cushing's syndrome were analyzed using chi-squared analy-
sis. Factors impacting upon the CushQoL-pet score were assessed
using nonparametric analyses (either Wilcoxon rank-sum test or
Krukshal-Wallis test). Statistical significance was set at <.05.
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3 | RESULTS
3.1 | CushQoL-pet development
3.1.1 | Item identification
From the focus group discussions, interviews, and reviews of relevant
literature, 32 HRQoL items specific to dogs with Cushing's syndrome
were identified.
3.1.2 | Item selection
A questionnaire was developed incorporating the 32 items identified.
During pretesting, 6 questions deemed inappropriate or ambiguous
were removed and 3 were reworded for clarification resulting in
26 HRQoL questions included in the online questionnaire.
3.1.3 | Item refinement
Owners of dogs with (n = 237) and without Cushing's syndrome
(n = 699) completed the online questionnaire. There were 95 incom-
plete responses that were excluded from analysis: 13 (6.2%) with Cus-
hing's syndrome and 82 (11.7%) without. Eight owners of dogs with
Cushing's syndrome answered the study about dogs that were no lon-
ger alive and 6 duplicate responses were identified and were
removed, resulting in 210 responses related to dogs with Cushing's
syndrome and 617 for dogs without Cushing's syndrome. No owners
identified their dog as having iatrogenic Cushing's.
When comparing responses to the HRQoL questions by owners of
dogs with or without Cushing's syndrome, no difference was observed
in the responses to “medication stress” or “off food” so these were
removed from the tool (P = .22 and P = .33, respectively). Based on cor-
relations between an individual question and all other HRQoL ques-
tions, 3 questions were removed (“frequency of urination”, “vet stress,”
and “begs for food”) as they were poorly correlated to the other items
(r = .29, .23, and .22, respectively), improving the internal consistency
of the score. A number of HRQoL questions were found to be highly
correlated with each other: “thirsty” with “emptying water bowl”
(r = .68) and “weak” with “struggles to walk” (r = .63). “Emptying water
bowl” and “weak” were removed from the score as these resulted in
the least change in Cronbach's alpha coefficient. The process of item
refinement reduced the number of items from 26 to 19 in the final
CushQoL-pet tool, with a Cronbach's alpha of α = .83 (Table 1).
All 32 items initially identified for inclusion in the online question-
naire which were subsequently retained or excluded from the final
tool, CushQoL-pet, are outlined (Supporting Information).
3.2 | Interpretation, validation, and reliability of
CushQoL-pet
The median HRQoL score for dogs with Cushing's syndrome using the
final tool was .35 (range .07–.77, interquartile range [IQR] .25–.46).
Dogs without Cushing's syndrome had a median score of .12
(range .00–.70, IQR .09–.19, P < .001). For dogs with Cushing's syn-
drome, no difference in the HRQoL tool score was found between
age groups (P = .84). Increasing HRQoL scores of dogs with Cushing's
syndrome were seen with increasing owner assessment scores
(Spearman's rho = .40, P < .001). Health-related quality-of-life scores
among the 3 non-Cushing's syndrome age groups and dogs with Cus-
hing's syndrome were statistically different (P < .001) (Figure 1).
Principal components analysis was conducted on the final 19 ques-
tions to identify grouping of questions within the tool and highlighted
3 principal components accounting for 58.2% of the data which were
retained for further analysis. Items clustering on differing components
suggested that component 1 represents the dog's demeanor
TABLE 1 Final items included in the Cushing's syndrome HRQoL
tool (CushQoL-pet) after question refinement
1 My dog is excessively thirsty
All the time (3), often (2), occasionally (1), never (0)
2 My dog urinates in the house
All the time (3), often (2), occasionally (1), never (0)
3 My dog is excessively hungry
All the time (3), often (2), occasionally (1), never (0)
4 My dog pants excessively
All the time (3), often (2), occasionally (1), never (0)
5 My dog appears to be gaining weight
All the time (3), often (2), occasionally (1), never (0)
6 My dog is depressed and quiet
All the time (3), often (2), occasionally (1), never (0)
7 My dog has no energy
All the time (3), often (2), occasionally (1), never (0)
8 My dog doesn't want to interact with other people / dogs
All the time (3), often (2), occasionally (1), never (0)
9 My dog is reluctant to play with me
All the time (3), often (2), occasionally (1), never (0)
10 My dog seems disorientated/confused
All the time (3), often (2), occasionally (1), never (0)
11 My dog's hair coat is in a poor condition
All the time (3), often (2), occasionally (1), never (0)
12 My dog's skin appears to be uncomfortable (eg, dry/tight)
All the time (3), often (2), occasionally (1), never (0)
13 My dog appears to be in poor physical condition (eg, muscle loss/
big belly)
All the time (3), often (2), occasionally (1), never (0)
14 I feel my dog's appearance gets negative comments
All the time (3), often (2), occasionally (1), never (0)
15 My dog struggles to walk very far
All the time (3), often (2), occasionally (1), never (0)
16 I worry about the future health of my dog
All the time (3), often (2), occasionally (1), never (0)
17 Mine and my dog's daily routine is being disrupted
All the time (3), often (2), occasionally (1), never (0)
18 I feel I am struggling to manage my dog's health
All the time (3), often (2), occasionally (1), never (0)
19 Currently I feel there is a strong bond between me and my dog
All the time (0), often (1), occasionally (2), never (3)
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(depressed [Q6], no energy [Q7], and reluctance to play [Q9];
Cronbach's α = .79), component 2 the dog's clinical signs of Cushing's
syndrome (thirst [Q1], urination [Q2], and hunger [Q3]; Cronbach's
α = .66), and component 3 the dog's appearance (hair coat [Q11], skin
[Q12], and poor physical condition [Q13]); Cronbach's α = .71
(Table 2). Kaiser–Meyer–Olkin postestimation was .82 indicating ade-
quate sample size and reliable results.
When assessing the reliability of the HRQoL questions, inter-rater
(n = 13, ICC = .88, 95% CI .55–.97) and intra-rater agreement (n = 15,
ICC = .78, 95% CI .49–.92) indicated good reliability. There was also a cor-
relation with Bland-Altman plots, which suggest good agreement of paired
owner and repeated owner responses for the HRQoL questions (Figure 2).
Test-retest results showed a correlation between the difference in the
2 CushQoL-pet scores (Spearman's rho = .64, P < .001) and how owners
described a change in their dogs quality-of-life (Table 3). Test-retest results
also showed a significant correlation between owners assessment of
quality-of-life and the CushQoL-pet score (rho = .69, P < .001).
3.3 | Evaluation of HRQoL in dogs with Cushing's
syndrome
Overall respondents originated from the United Kingdom (n = 622,
69.9%), United States (184, 20.7%), and 25 other countries (84, 9.4%).
Median age of dogs with Cushing's syndrome was 11 years (IQR
F IGURE 1 CushQoL-pet scores in dogs with Cushing's syndrome
(median .35, IQR .25–.46) and those without Cushing's syndrome,
separated by age groups (<7 years [.11, IQR .07–.16]; 7–11 years [.14,
IQR .11–.19]; >11 years [.19, IQR .14–.32])
TABLE 2 Principal component analysis factor loadings to the 19
questions of the CushQoL-pet. Principal component (PC) 1, PC2, and
PC3 explained 58.2% of the data variance. Question loadings closest
to −1 or 1 are highlighted, indicate the strongest influence on that
principal component
CushQoL-pet question PC1 PC2 PC3
Thirsty .13 .39 .18
Urinates in the house .11 −.19 .16
Hungry .11 .35 .13
Pants .13 .37 .29
Weight gain .16 .38 .30
Depressed .33 −.22 −.01
No energy .35 −.11 .11
Does not interact .30 −.26 .18
Reluctant to play .38 −.29 .04
Disorientated .25 −.26 .04
Poor hair coat .20 .20 −.42
Dry/tight skin .19 .26 −.42
Poor physical condition .21 .10 −.10
Negative comments .23 .20 −.39
Struggles to walk .32 −.07 .12
Future health concern .18 .16 .11
Disrupted routine .29 .02 .04
Owner struggling .29 −.01 −.02
Dog-owner bond −.15 .23 .19
F IGURE 2 Bland-Altman plots of inter-rater (n = 13) and intra-
rater (n = 15) owner scores of CushQoL-pet
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9–13) and dogs without Cushing's syndrome was 7 years (IQR 4–10).
The most represented breeds of dog with Cushing's syndrome were
crossbreeds (n = 37, 17.6%), Border Terriers (14, 6.7%), Bichon Frise
(12, 5.7%), and Jack Russell Terriers (9, 4.3%). Dogs with Cushing's
syndrome were less likely to be insured (n = 65, 31.1%) than those
without Cushing's syndrome (388, 57.0%, P = .002). Owners of dogs
with Cushing's reported to spend >8 hours a day with their dogs
(145, (69.1%), with 206 (98.1%) describing themselves as the primary-
care giver to their dog. Owners of dogs with and without Cushing's
syndrome differed in how they viewed their dogs current quality-of-
life (P < .001), with the reported quality-of-life for dogs with Cushing's
syndrome generally poorer. Eighty (38.1%) owners of dogs with Cus-
hing's syndrome described their dog's current quality-of-life “as good
as it could possibly be.” Most dogs with Cushing's syndrome were first
diagnosed over 12 months previous to the questionnaire
(104, 49.5%), with 160 (76.2%) currently on trilostane (Vetoryl Cap-
sules, Dechra Veterinary Products Ltd, Shrewsbury, United Kingdom)
treatment with 110 (68.8%) receiving their trilostane once daily.
When owners were asked about their dog developing an Addisonian
crisis, 43 (20.5%) did not know what an Addisonian crisis was and
52 (24.8%) never worried about it. Owners of 165 (80.5%) dogs with
Cushing's syndrome felt they understood the disease either “very
well” or “fairly well.” The average time to complete the full online
questionnaire was 6 minutes.
The questions reported by owners of dogs with Cushing's syn-
drome as most important were those that explored whether Cushing's
syndrome affects the bond with their pet and how much they worry
about their pet's future health (Figure 3). The least important items
were about their pet's appearance and interaction with other people/
dogs. When assessing the reliability of paired owner reported HRQoL
question importance, there was moderate to poor agreement of inter-
rater (ICC = .53, 95% CI −.77 to .88) and intra-rater assessments
(ICC = .54, 95% CI −.55 to .91). Increasing age, having a comorbidity,
or increasing length of time as diagnosis were not statistically associ-
ated with having a better HRQoL in dogs with Cushing's syndrome
(P = .84, .34, and .08, respectively). Dogs currently on treatment with
trilostane (.33, IQR .23–.44) were reported to have a better HRQoL
than those on alternative medical treatment or no treatment (.36,
IQR .33–.54, P = .04) (Table 4).
TABLE 3 Median test-retest CushQoL-pet scores at initial completion and at 3 month follow-up, stratified by owner assessment of change in
their dog's quality-of-life in this time period (n = 71). Spearman's rho = .64, p < .001
Owner assessment (n = 71)
Initial CushQoL-pet score
(median, IQR)




A great deal better (n = 7) .35 (.28–.42) .18 (.11–.25) −.16
Quite a lot better (n = 11) .37 (.16–.54) .21 (.07–.39) −.14
A little better (n = 16) .34 (.26–.44) .27 (.19–.37) −.08
No difference (n = 15) .32 (.21–.42) .28 (.18–.42) +.02
A little worse (n = 14) .39 (.23–.42) .41 (.28–.46) +.04
Quite a lot worse (n = 2) .51 (.47–.54) .54 (.52–.56) +.04
A great deal worse (=6) .31 (.25–.42) .40 (.39–.70) +.08
F IGURE 3 Proportional responses of perceived HRQoL
question importance to owners and their dogs with Cushing's
syndrome (n = 210)
TABLE 4 Factors associated with HRQoL score in dogs with
Cushing's syndrome (n = 210)
Variable Cases (%)
Median HRQoL
score (IQR) P value1
Trilostane .04
Yes 159 (77.2) .33 (.23–.44)
No 47 (22.8) .36 (.33–.54)
Age .84
<7 17 (8.2) .37 (.28–.53)
7 to ≤11 103 (50.0) .37 (.23–.47)
>11 86 (41.8) .35 (.26–.44)
Comorbidity .34
Yes 138 (66.7) .35 (.25–.47)
No 69 (33.3) .33 (.25–.42)
Time since diagnosis .08
≤1 month 23 (11.2) .39 (.33–.58)
>1–12 months 80 (38.8) .35 (.23–.49)
>12 months 103 (50.0) .33 (.25–.44)
1Nonparametric test P value.
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4 | DISCUSSION
The developed CushQoL-pet quantifies the HRQoL of dogs with Cus-
hing's syndrome and can be a useful tool for clinicians and researchers
to aid clinical assessment of dogs with Cushing's syndrome. The final
19-question tool was shown to be interpretable, valid, and reliable for
owner-completion in a population of dogs with Cushing's syndrome.
These are deemed important qualities of a quality-of-life tool8,12,29;
however, they are infrequently assessed in published quality-of-life
assessments in dogs.29 The internal consistency of CushQoL-pet indi-
cated good reliability to measure the same latent concept; “HRQoL of
dogs with Cushing's syndrome” (α = .83). Inter-rater, intra-rater, and
test-retest assessments of the tool further indicated reliability of
owner completion of CushQoL-pet. The overall reliability of the inter-
rater was slightly higher than the intra-rater reliability. This suggests
that 2 different owners had better agreement than the same owner
repeating the questionnaire twice within a 2 week time period. How-
ever, the reverse could have been expected. This could be that
changes in the dogs' HRQoL were truly observed in a 2 week time
period. Another suggestion could be that owners repeating the ques-
tionnaire over a short time period changed their behavior when famil-
iarized with the questions and became accustomed to the format. The
inter-rater scores appeared to have greater agreement for higher
scores, indicating a poorer HRQoL, than lower scores when examining
the Bland-Altman plot. This suggests that 2 owners had the greatest
agreement on their pet's HRQoL when it was poor. These reliability
assessments would be interesting to explore further with a larger
sample size.
The CushQoL-pet score of dogs with Cushing's syndrome showed
a general increasing trend with poorer owner-perceived quality-of-life,
further validating the tool. However, the moderate correlation (r = .41)
could suggest the value of more detailed assessment encompassing the
multiple facets of HRQoL, above a singular direct question about over-
all quality-of-life. There was also a difference observed in the
CushQoL-pet score between dogs with and without Cushing's syn-
drome (P < .001). When examining dogs without Cushing's syndrome
by different age groups and health status, there was still a significant
difference in their CushQoL-pet score. However, there was no differ-
ence in CushQoL-pet scores of those with Cushing's syndrome across
different age groups or with comorbidities (P = .84 and .34, respec-
tively). This indicates that the HRQoL described by CushQoL-pet is
specific to Cushing's syndrome and suggests the score is not highly
influenced by the dog's age or other morbidities which has been a con-
cern regarding the application of disease-specific HRQoL tools.29 When
comparing the changes in the median test-retest scores with the owner
assessment of the change in their dog's quality-of-life over the same
time period, the tool was able to detect the direction of change (either
improvement or deterioration). The median score differences suggested
that the tool was better at indicating improvement in HRQoL than a
deterioration in HRQoL. A decreased score of about −.10 indicated
owner-assessed improvement and an increase of +.05 indicated deteri-
oration. This study focused purely on owner-reported HRQoL,
unaffected by veterinarian's opinions, as this type of reporting is cur-
rently lacking in the veterinary literature. Nevertheless, the lack of vet-
erinarian assessment of health status is a potential limitation of this
study. Future replication of results within a practice setting, alongside
veterinarian evaluation of a clinical assessment, could provide further
evidence of reliability and validity.30 In particular, assessment of
changes in owner questionnaire response behavior over time and eval-
uation of CushQoL-pet's responsiveness to changes in HRQoL would
be of interest.31
The design of the tool was intended for it to be quick for owners
to complete, as well as being easy to interpret for veterinarians to
encourage its uptake in primary-care practice. The tool is comparable
in length to other HRQoL tools,13,14,32 with some other published
quality-of-life tools noticeably longer.11,33,34 The average time to
complete the questionnaire during this study was 6 minutes. How-
ever, this included a number of additional questions that will not be
included in the final version used in practice and therefore completion
of the CushQoL-pet in a clinical setting is likely much shorter than
this. A suggested integration of the tool into practice would be during
therapeutic monitoring consultations. During refinement of the tool,
7 questions were removed as they were either shown to be poorly
correlated with the other questions, not specific to the Cushing's syn-
drome dog population or were highly correlated with another ques-
tion, indicating repetition. A recent study found that the shortening of
a much longer tool was valid and would likely increase its acceptabil-
ity.35 A scoring system on a 0–1 scale was used without weighting of
the questions to ensure the final score was easy to calculate and inter-
pret within primary-care practice.8,36
Three principal components were retained for further analysis
with 3 subsets of questions identified within the tool. Although the
individual factor loadings identified were weakly correlated to the
overall component (.30 ≤ r < .45), the subsets were clinically justifiable
and generally had good internal consistency. The subset structures
and the reliability estimates provide evidence of internal coherence
and construct validity of the tool. Questions related to the demeanor
of dogs with Cushing's syndrome described the largest explanatory
principal component in the PCA. This could indicate that demeanor
should be given increased emphasis in clinical evaluation of affected
dogs and highlights an interesting parallel with the human situation
where depression is thought to have a substantial impact on HRQoL,
with the resulting hypercortisolism associated with psychiatric and
neurocognitive disorders in human patients with Cushing's syn-
drome.37 Fatigability and muscle weakness have a detrimental effect
on the HRQoL of people with Cushing's syndrome.17,38 With some
similarities between Cushing's syndrome in people and dogs, there is
the possibility that these more subtle physiological and psychological
effects could be overlooked in dogs. Therefore, a comprehensive
assessment of the HRQoL in dogs with Cushing's syndrome could
bring certain properties of the disease to light.
Areas described of highest importance to owners and their pets
generally related to areas of “owner impact.” This is interesting but
perhaps unsurprising, reflecting similar findings in other studies.10,39
Owner-related questions included within the HRQoL tool were those
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that impact upon the dog and potentially affect how Cushing's syn-
drome is managed.40 Owner factors deemed relevant were deter-
mined in the pretesting of the questionnaire with expert opinions
across a range of disciplines. These include the current bond between
the owner and dog and how well owners feel they are managing their
dog's health. In veterinary medicine, direct evaluation of quality-of-life
is not possible (dogs cannot directly communicate how they feel),
therefore individualization of a HRQoL tool for animals is difficult. It
was decided not to weigh the tool by incorporating owner assessed
importance into the final tool which could have taken individualized
dog needs and preferences into account.29 Importance score reliability
assessments indicated these questions were subjective, with disagree-
ment between 2 owners' views (ICC = .53, 95% CI −.77 to .88) and
variations in repeated owner response within a 2-week period
(ICC = .54, 95% CI −.55 to .91) therefore affecting the overall score
reliability. Additionally the increased perceived importance of owner
specific factors potentially highlighted a limitation of proxy reporting
by owners. It cannot be assumed that proxy assessment will be a true
reflection of the HRQoL of a dog with Cushing's syndrome. Studies
evaluating quality-of-life in children via proxy have compared the
results to the individuals own experience with varying views of the
assessment.41,42 The owner rather than the veterinarian was used as
the proxy in the current study because of their closer relationship and
time spent with their pet.
Current age, having a comorbidity and time since diagnosis, was
not associated with the HRQoL of dogs with Cushing's syndrome.
There are no studies currently that have quantitatively examined risk
factors associated with a poorer HRQoL in dogs with Cushing's syn-
drome. A recent study examined the factors affecting euthanasia deci-
sions in dogs with diabetes mellitus finding age, concurrent disease,
and costs were considered of high importance by clinicians.43 It could
be assumed that similar factors would have been associated with the
HRQoL of dogs with Cushing's syndrome. Additionally, it could be
suspected that age would have a negative effect on HRQoL because
of its association with reduced survival.44-46 Treatment with trilostane
was weakly associated with a better HRQoL (P = .04) and the differ-
ence detected only small (.03). Studies examining survival and clinical
responses to trilostane are favorable; therefore, this could truly be a
reflection of improved HRQoL in trilostane treated dogs.46-49 The
duration of time dogs have been on treatment and the reasons for
dogs in this population not receiving trilostane are unknown; there-
fore, the weak association found might be confounded when taking
other factors into consideration. Future examination of changes in
HRQoL before and after commencement of trilostane in a clinical set-
ting would be interesting.
The study had some limitations. As with any questionnaire, there
is the potential for recall bias.50,51 This was considered in the study
methodology by not mentioning planned assessment of quality-of-life
in the introduction to avoid owners answering questions with a
preconceived view of quality-of-life. The methods of recruitment used
could have resulted in selection bias of the owners that participated.
Owners participating in this study might not have been representative
of the general underlying population. The proportion of incomplete
responses was greater for owners of dogs without Cushing's syn-
drome. This could be because owners of dogs with Cushing's syn-
drome would be more invested in this research than owners of
control dogs. Awareness of the questionnaire was raised through a
variety of different sources and recruitment did include some social
media and webpage promotion. The methods of promotion via this
method were directed as much as possible, primarily using veterinary
sites to target veterinary professionals and owners of dogs with Cus-
hing's syndrome (such as the Veterinary Information Network, Dechra
Veterinary Products Ltd, and the Royal Veterinary College). The use
of these platforms was to reach a large numbers of owners of dogs
with Cushing's syndrome, which is not a highly prevalent disease
within veterinary practices.52 Targeted focus on veterinary practice
promotion of the study to clients aimed to increase the likelihood of a
veterinarian confirmed diagnosis of Cushing's syndrome as well as to
increase the representativeness of participation. However, it is possi-
ble that some owners might have completed the tool without their
dog having received a veterinary-confirmed diagnosis of Cushing's
syndrome. Selection bias could have resulted because responses were
only completed online. The majority of respondents were from the
United Kingdom and the second largest proportion was from the
United States. Inclusion of respondents across several countries was
deemed to provide a broad view of the HRQoL of Cushing's
syndrome.
5 | CONCLUSIONS
In conclusion, CushQoL-pet is the first tool to quantify the HRQoL of
dogs with Cushing's syndrome. The validated tool can be used within
practice and research to aid clinical assessment of dogs with the dis-
ease and could provide a supplementary tool to current monitoring
methods.
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